New HIV drug could revolutionize treatment for the elderly
A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
Promising drug compound attacks fat from genetic roots
A new oral drug compound, TLC-2716, shows promise in significantly reducing blood fat levels linked to fatal heart diseases.
Are Generic Drugs Cut to Create New Drugs? … It’s a Misdiagnosis
The ongoing debate surrounding the Ministry of Health and Welfare's proposal to lower the prices of generic drugs in South Korea has raised concerns about its implications for new drug development and the pharmaceutical industry.
The CNIO closes its cancer drug development and diagnostic units
The National Center for Cancer Research (CNIO) has shut down its cancer diagnosis and drug development units while launching a new action plan focusing on artificial intelligence and computational methodologies.
The CNIO closes its cancer diagnosis and new drug development units
The National Cancer Research Center (CNIO) will close three scientific units, impacting over 20 employees amid an unprecedented crisis.